PEGGY KELLY: Open Payments
NPI 1265727960 · FORT SMITH, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$452 in 27 payments from 14 companies in 2025. Trend: 2023 $1,011 · 2024 $574 · 2025 $452
Food & beverage: $452
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $74 |
| Novo Nordisk Inc | 4 | $69 |
| Sumitomo Pharma America, Inc. | 2 | $37 |
| ABBVIE INC. | 2 | $36 |
| Exact Sciences Corporation | 2 | $32 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $31 |
| PFIZER INC. | 2 | $30 |
| Amgen Inc. | 2 | $28 |
| GlaxoSmithKline, LLC. | 2 | $27 |
| Dexcom, Inc. | 1 | $20 |
Products named: BREZTRI, GEMTESA, Ozempic, AIRSUPRA, Cologuard Collection Kit, JARDIANCE, UBRELVY, Dexcom G6 Transmitter.
Industry payments across AR — which companies pay providers there.
